Study on Cardiac Output Evaluation Based on Wearable Monitoring Data
1 other identifier
observational
300
0 countries
N/A
Brief Summary
Based on the monitoring data of wearable devices, with cardiac output (CO) as the gold standard, this study intends to develop a non-invasive evaluation model of CO based on wearable data, and optimize the parameters to realize the cardiac capacity detection function in resting and exercise states on the wearable device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2025
CompletedStudy Start
First participant enrolled
April 20, 2025
CompletedFirst Posted
Study publicly available on registry
April 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
April 22, 2025
April 1, 2025
1.6 years
January 17, 2025
April 14, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
cardiac output
Taking cardiac function indicators such as cardiac output by echocardiography as the gold standard, using wearable device monitoring data(Photoplethysmographic pulse wave), the resting state cardiac output artificial intelligence machine learning model was established, and the sensitivity, specificity, positive predictive value, negative predictive value, F1 score, diagnostic efficiency Area Under Curve (AUC), and the sensitivity, specificity, positive predictive value, negative predictive value, F1 score, diagnostic efficiency of the model were calculated. AUC), precision and precision-recall curves were used to evaluate the performance of the model.
From enrollment to the end of follow-up at 1 month
Secondary Outcomes (1)
Heart failure
From enrollment to the end of follow-up at 1 month
Interventions
Cardiac output (CO) was measured after exercise intervention in patients with normal cardiac function
Eligibility Criteria
Two hundred HF patients with an left ventricular ejection fraction (LVEF) of less than 50% and 100 normal cardiac function subjects with an LVEF of 50% or greater were enrolled
You may qualify if:
- Over 18 years old
- Left ventricular ejection fraction (Left ventricular ejection fraction, LVEF) \< 50%(200 subjects)
- Left ventricular ejection fraction (Left ventricular ejection fraction, LVEF) ≥50% (100 subjects)
- Able to use smart phones and operate wearable devices such as wristbands/watches
You may not qualify if:
- Patients with pacemaker implantation
- No smartphone
- Currently participating in other clinical trials
- Lactating women
- Pregnant Women
- Unable to run and ride due to personal physical and external reasons (subjects participating in the exercise state cardiac output model study)
- Physical examination results in the past year have clear cardiovascular, metabolic, bone and joint related diseases that have exercise risk, or have diseases and related potential health risks confirmed by the self-examination form of physical status before exercise (participants in the exercise state cardiac output model study)
- No informed consent was obtained
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2025
First Posted
April 22, 2025
Study Start
April 20, 2025
Primary Completion (Estimated)
November 30, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
April 22, 2025
Record last verified: 2025-04